What is Insilico Medicine's contact information?

Insilico Medicine's contact information: bd@insilico.com, recruiting@insilico.com, privacy@insilico.com, +14434517212.

How many employees does Insilico Medicine have?

Insilico Medicine has 300 employees.

What industry does Insilico Medicine belong to?

Insilico Medicine is in the industry of: Pharmaceuticals, Biotechnology, Information Technology, Biotechnology Research.

What are Insilico Medicine's official social media profiles?

Insilico Medicine Linkedin Page Insilico Medicine Facebook Page Insilico Medicine Twitter Page

What tech stack does Insilico Medicine use?

Some of the popular technologies that Insilico Medicine uses are: Google Analytics, Linkedin Insight Tag, Tilda, Google Workspace.

What are Insilico Medicine's office addresses?

Insilico Medicine has 10 known office addresses: 1000 Massachusetts Avenue, Suite 126, Cambridge, MA 02138 Park Avenue South, NY, NY, Suite 010, 10010 1250 René-Lévesque Ouest, Suite 3710, Montréal, Québec, Canada H3B 4W8 Level 6, Unit 08, Block A, IRENA HQ Building Masdar City, Abu Dhabi, United Arab Emirates 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai Suite 1303, No. 333, Sec. 1, Keelung Rd., Xinyi Dist., Taipei, 110, Taiwan Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Pak Shek Kok, New Territories, Hong Kong 1000 Massachusetts Ave Boston, Massachusetts 02138, US 345 Park Ave S New York, NY 10010, US 1 Science Park East Avenue, Hong Kong Science Park, Pak Shek Kok Unit 307A, Core Building 1 New Territories, HK.

What is Insilico Medicine's estimated annual revenue?

Insilico Medicine's revenue is $20,000,000

What is Insilico Medicine's open headcount?

Insilico Medicine has 14 job postings.

What is the number of ad campaigns for Insilico Medicine?

Insilico Medicine has 2 advertisements.

What is the number of recent news articles about Insilico Medicine?

Insilico Medicine has 95 news articles.

Insilico Medicine - Pubrio Company Profile & Intent

Insilico Medicine

United States · Biotechnology Research

Pharmaceuticals

Biotechnology

Information Technology

Biotechnology Research

Insilico Medicine, a clinical stage biotech company powered by generative AI, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases.